Skin replacement with Bioplast fibrin in Ophthalmology.
The study includes 40 cases of skin replacement performed by an ophthalmologist over a period of 4 years. An absorbable implant material, Bioplast fibrin, was used as a graft following the extirpation of 12 eyelid tumors, the treatment of eight fresh, destructive skin injuries, and the removal of deforming scars around the eyes, in 20 cases. The biocompatible implant provided barrier properties preventing infection or excessive fluid loss. The resorption rate was adjusted to 3-4 weeks. These grafts were gradually replaced by new epithelial tissue growing in from the periphery of the wound edge. The new tissue had the elasticity and cosmetic appearance of surrounding skin. Thus, small periorbital skin tumors can now be removed without the necessity of doing a split thickness skin graft to cover the defect.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001672:Biocompatible Materials / Q000627:therapeutic use*; D002921:Cicatrix / Q000601:surgery; D062109:Dermatologic Surgical Procedures; D005131:Eye Injuries / Q000601:surgery*; D005142:Eyelid Neoplasms / Q000601:surgery*; D005260:Female; D005337:Fibrin / Q000627:therapeutic use*; D006099:Granuloma / Q000601:surgery; D006801:Humans; D008297:Male; D008875:Middle Aged; D012867:Skin / Q000293:injuries; D012871:Skin Diseases / Q000601:surgery
D001672:Biocompatible Materials; D005337:Fibrin